Articles/ Cancer/ ESMO2016-related/ UK & Europe/ Views and analysis ESMO 2016: Spectacular data in NSCLC, but many questions remain Andrew McConaghie 0 Comment New immunotherapies are producing impressive results in lung cancer Share X ESMO 2016: Spectacular data in NSCLC, but many questions remain https://pharmaphorum.com/articles/esmo-2016-spectacular-immunotherapy-data-lung-cancer-many-questions-remain/
ESMO2016-related/ Views and analysis Spotlight on – The Future of Oncology Clinical Trials ppconnwpadmin #pharmanews, cancer, Clinical, clinical trials, immuno-oncology, Oncology, pharma, pharmaviewsandanalysis, quintilesIMS, Spotlight, thought leadership, trials, viewsandanalysis 0 Comment We present the latest insight and analysis of the rapidly evolving field of cancer therapeutics and immuno-therapy, with Share X Spotlight on – The Future of Oncology Clinical Trials https://pharmaphorum.com/views-and-analysis/future-oncology-focus/
